Workflow
688399,高管集体降薪!

Core Viewpoint - The company, Shuoshi Biotechnology, announced voluntary salary reductions by its board members and senior management to support operational cost optimization and enhance competitiveness amid challenging global economic conditions [2][4]. Group 1: Salary Reductions - The honorary chairman, Fang Yongsheng, and the chairman and general manager, Wang Guoqiang, will have their annual salaries reduced by 50% starting from August 15, 2025 [3]. - Other executives, including Liu Zhonghua and Hu Yuanyuan, will see a 40% reduction in their annual salaries, while the financial director, Meng Yuanyuan, and employee supervisors will have reductions of 10% and 5%, respectively [3]. Group 2: Company Performance - In the first half of 2025, the company reported revenue of 176 million yuan, a year-on-year decrease of 1.05%, and a net profit attributable to shareholders of 3.99 million yuan, down 86.35% year-on-year [4]. Group 3: Strategic Initiatives - The company emphasized that the salary adjustments reflect management's recognition of the company's intrinsic value and confidence in future growth prospects [4]. - In addition to salary cuts, the company plans to implement cost-reduction measures and enhance market expansion efforts to improve operational efficiency and competitiveness [4].